The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review
Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease that can lead to end-stage liver disease needing a liver transplant. Many pharmacological approaches are used to reduce the disease progression in NAFLD. However, current strategies remain ineffective to reverse the progressi...
Saved in:
Main Authors: | Seyedeh Alia Moosavian, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Bioinorganic Chemistry and Applications |
Online Access: | http://dx.doi.org/10.1155/2021/4041415 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Predictive Role of Parathyroid Hormone for Nonalcoholic Fatty Liver Disease following Bariatric Surgery
by: Tannaz Jamialahmadi, et al.
Published: (2022-01-01) -
Pathophysiology of Physical Inactivity-Dependent Insulin Resistance: A Theoretical Mechanistic Review Emphasizing Clinical Evidence
by: Habib Yaribeygi, et al.
Published: (2021-01-01) -
The Role of Gut Microbiota Modification in Nonalcoholic Fatty Liver Disease Treatment Strategies
by: Hessam Yaghmaei, et al.
Published: (2024-01-01) -
Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
by: Melanie D Beaton
Published: (2012-01-01) -
Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease
by: Caihua Wang, et al.
Published: (2019-01-01)